Sanofi slams judge’s harm assessment in denying injector pen injunction

Christian Dimitriadis 2019-02-08 9:39 pm By Miklos Bolza | Sydney

Please login to bookmark

A judge that rejected a bid by Sanofi-Aventis for an injunction blocking rival Alphapharm from listing an insulin injector pen on the PBS erred in his consideration of the harm it would face, the drug giant has told the Full Federal Court.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au